196 related articles for article (PubMed ID: 28078433)
1. A meta-analysis of the clinicopathological characteristics and survival outcomes of inflammatory bowel disease associated colorectal cancer.
Reynolds IS; O'Toole A; Deasy J; McNamara DA; Burke JP
Int J Colorectal Dis; 2017 Apr; 32(4):443-451. PubMed ID: 28078433
[TBL] [Abstract][Full Text] [Related]
2. Clinical features, treatment, and survival of patients with colorectal cancer with or without inflammatory bowel disease.
Ali RA; Dooley C; Comber H; Newell J; Egan LJ
Clin Gastroenterol Hepatol; 2011 Jul; 9(7):584-9.e1-2. PubMed ID: 21565283
[TBL] [Abstract][Full Text] [Related]
3. A matched case-control study of IBD-associated colorectal cancer: IBD portends worse outcome.
Hrabe JE; Byrn JC; Button AM; Zamba GK; Kapadia MR; Mezhir JJ
J Surg Oncol; 2014 Feb; 109(2):117-21. PubMed ID: 24132737
[TBL] [Abstract][Full Text] [Related]
4. Survival of Colorectal Cancer in Patients With or Without Inflammatory Bowel Disease: A Meta-Analysis.
Ou B; Zhao J; Guan S; Lu A
Dig Dis Sci; 2016 Mar; 61(3):881-9. PubMed ID: 26518415
[TBL] [Abstract][Full Text] [Related]
5. Age-Related Survival Differences in Patients With Inflammatory Bowel Disease-Associated Colorectal Cancer: A Population-Based Cohort Study.
Bogach J; Pond G; Eskicioglu C; Seow H
Inflamm Bowel Dis; 2019 Nov; 25(12):1957-1965. PubMed ID: 31066449
[TBL] [Abstract][Full Text] [Related]
6. Survival Outcomes and Clinicopathological Features in Inflammatory Bowel Disease-associated Colorectal Cancer: A Systematic Review and Meta-analysis.
Lu C; Schardey J; Zhang T; Crispin A; Wirth U; Karcz KW; Bazhin AV; Andrassy J; Werner J; Kühn F
Ann Surg; 2022 Nov; 276(5):e319-e330. PubMed ID: 34913897
[TBL] [Abstract][Full Text] [Related]
7. KRAS and TP53 mutations in inflammatory bowel disease-associated colorectal cancer: a meta-analysis.
Du L; Kim JJ; Shen J; Chen B; Dai N
Oncotarget; 2017 Mar; 8(13):22175-22186. PubMed ID: 28077799
[TBL] [Abstract][Full Text] [Related]
8. The risk of inflammatory bowel disease-related colorectal carcinoma is limited: results from a nationwide nested case-control study.
Baars JE; Looman CW; Steyerberg EW; Beukers R; Tan AC; Weusten BL; Kuipers EJ; van der Woude CJ
Am J Gastroenterol; 2011 Feb; 106(2):319-28. PubMed ID: 21045815
[TBL] [Abstract][Full Text] [Related]
9. Colorectal cancer prognosis among patients with inflammatory bowel disease.
Delaunoit T; Limburg PJ; Goldberg RM; Lymp JF; Loftus EV
Clin Gastroenterol Hepatol; 2006 Mar; 4(3):335-42. PubMed ID: 16527697
[TBL] [Abstract][Full Text] [Related]
10. Oncological outcomes of IBD-associated versus sporadic colorectal cancer in modern era: a matched case-control study.
Thicoïpé A; Laharie D; Smith D; Chabrun E; Rullier A; Poullenot F; Rullier E; Denost Q
Int J Colorectal Dis; 2018 Jul; 33(7):963-966. PubMed ID: 29675590
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy Tolerance and Oncologic Outcomes in Patients With Colorectal Cancer With and Without Inflammatory Bowel Disease.
Axelrad J; Kriplani A; Ozbek U; Harpaz N; Colombel JF; Itzkowitz S; Holcombe RF; Ang C
Clin Colorectal Cancer; 2017 Sep; 16(3):e205-e210. PubMed ID: 27742264
[TBL] [Abstract][Full Text] [Related]
12. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
Brackmann S; Andersen SN; Aamodt G; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH
Scand J Gastroenterol; 2009; 44(1):46-55. PubMed ID: 18609187
[TBL] [Abstract][Full Text] [Related]
13. Associations between single-nucleotide polymorphisms and inflammatory bowel disease-associated colorectal cancers in inflammatory bowel disease patients: a meta-analysis.
Li H; Jin Z; Li X; Wu L; Jin J
Clin Transl Oncol; 2017 Aug; 19(8):1018-1027. PubMed ID: 28243990
[TBL] [Abstract][Full Text] [Related]
14. The outcome of patients with inflammatory bowel disease-associated colorectal cancer is not worse than that of patients with sporadic colorectal cancer-a matched-pair analysis of survival.
Vitali F; Wein A; Rath T; Eckstein M; Neufert C; Siebler J; Atreya R; Hartmann A; Hohenberger W; Weber K; Neurath MF; Grützmann R; Merkel S
Int J Colorectal Dis; 2022 Feb; 37(2):381-391. PubMed ID: 34865179
[TBL] [Abstract][Full Text] [Related]
15. Risk factors of colorectal cancer in inflammatory bowel disease.
Bansal P; Sonnenberg A
Am J Gastroenterol; 1996 Jan; 91(1):44-8. PubMed ID: 8561142
[TBL] [Abstract][Full Text] [Related]
16. Colitis-Associated Colorectal Cancer Survival is Comparable to Sporadic Cases after Surgery: a Matched-Pair Analysis.
Raje P; Sonal S; Qwaider YZ; Sell NM; Stafford CE; Boudreau C; Schneider D; Ike A; Kunitake H; Berger DL; Ricciardi R; Bordeianou LG; Cauley CE; Lee GC; Goldstone RN
J Gastrointest Surg; 2023 Jul; 27(7):1423-1428. PubMed ID: 37165158
[TBL] [Abstract][Full Text] [Related]
17. Outcomes from IBD-associated and non-IBD-associated colorectal cancer: a Surveillance Epidemiology and End Results Medicare study.
Gearhart SL; Nathan H; Pawlik TM; Wick E; Efron J; Shore AD
Dis Colon Rectum; 2012 Mar; 55(3):270-7. PubMed ID: 22469793
[TBL] [Abstract][Full Text] [Related]
18. Association Between Inflammatory Bowel Disease and Colorectal Cancer Stage of Disease and Survival.
Taylor CC; Millien VO; Hou JK; Massarweh NN
J Surg Res; 2020 Mar; 247():77-85. PubMed ID: 31767275
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcome of IBD-associated versus sporadic colorectal cancer: a matched-pair analysis.
Renz BW; Thasler WE; Preissler G; Heide T; Khalil PN; Mikhailov M; Jauch KW; Kreis ME; Rentsch M; Kleespies A
J Gastrointest Surg; 2013 May; 17(5):981-90. PubMed ID: 23475629
[TBL] [Abstract][Full Text] [Related]
20. Radiation therapy in patients with inflammatory bowel disease and colorectal cancer: risks and benefits.
Chang BW; Kumar AM; Koyfman SA; Kalady M; Lavery I; Abdel-Wahab M
Int J Colorectal Dis; 2015 Mar; 30(3):403-8. PubMed ID: 25564345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
